Key result
Endothelin-1 and endothelin-3 caused dose-dependent increases in coronary perfusion pressure that were mediated by both ETA and ETB receptors in the perfused rat heart.
Both ETA and ETB receptor subtypes mediate endothelin-induced coronary vasoconstriction in the rat heart.
Answers are grounded in this paper and cite their sources.
ETB mediation of coronary vasoconstriction indicated in vitro; leaves open relevance to human disease and therapy.
The effects of endothelin-1 (ET-1) are mediated by two subclasses of the endothelin receptor, ETA and ETB. The Langendorff perfused rat heart was used to determine the endothelin receptor subtype mediating rat coronary vasoconstriction. ET-1 (EC50 = 1.5 x 10(-10) M) and endothelin-3 (ET-3) (10(-11)-3 x 10(-8) M) caused dose-dependent increases in coronary perfusion pressure. BQ-123, a selective antagonist of the ETA-receptor subtype, did not cause a parallel shift in the dose-response curves of ET-1 or ET-3. In the presence of 1-3 x 10(-6) M BQ-123, ET-1 and ET-3 exhibited biphasic dose-response curves, suggesting that vasoconstriction was caused by two receptors. The ETB-selective agonist Suc-[Glu9,Ala11,15]-ET-1(8-21) (IRL 1620) maximally increased perfusion pressure by approximately 50% of the maximal response to ET-1 and was not inhibited by BQ-123. These data suggest that the rat coronary vasoconstrictor effects of ET-1 and ET-3 are mediated by both ETA and ETB receptors.
No takes yet. Share an insight, caveat, or question.
Joseph L. Balwierczak (1993) studied this question. Endothelin-1 and Endothelin-3 was evaluated on Coronary perfusion pressure. Endothelin-1 and endothelin-3 caused dose-dependent increases in coronary perfusion pressure that were mediated by both ETA and ETB receptors in the perfused rat heart.
Synapse has enriched 10 related papers. Consider them for comparative context: